Resources

Diamyd Medical AB announced today details of its Phase III clinical protocol and plans in the US for Diamyd®, the company’s lead drug candidate for the treatment autoimmune diabetes, type 1 diabetes and Latent Autoimmune Diabetes of Adults (LADA)

We know that heart attacks and strokes occur most frequently in the early-morning hours, but now we know why.

A new study sheds additional light on how erectile dysfunction (ED) interacts with diabetes. The study is another step in uncovering the link between the two disorders, and may lead to improved efficacy in erectile dysfunction treatments.

Practicing endocrinologists are in short supply in many areas of the country, and the situation only has worsened since a 2003 study that showed the national supply to be 12% lower than demand, according to several experts

Doctors in the United States have raised concerns that there could be a connection between diabetes and Alzheimer’s disease.

The number of young children with Type 1 diabetes has risen dramatically in the last 20 years, a study suggests.

54 Million Americans have pre-diabetes and according to a new study, periodontal disease can be a possible cause.

FDA Okays First Direct Renin Inhibitor for Hypertension The FDA has approved aliskiren (Tektuma), the first oral direct renin inhibitor for treatment of hypertension. The drug is the first in a new class of agents known as oral renin inhibitors and is approved for the treatment of high blood pressure …

Premenopausal women who were assigned to follow the Atkins diet for one year lost more weight and improved their glucose, lipids and blood pressure, when compared to women who were assigned to follow the Zone, Ornish and LEARN diets, according to a study in the March 7 issue of JAMA.

Intensive care physicians need to “think hard and long” about aiming for tight glycemic control. “We need to be very conservative about starting insulin regimens the minute someone comes into the ICU.”